A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

NCT07438444 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Obesity
Overweight

Interventions

DRUG: Tirzepatide

Sponsor

Eli Lilly and Company